Vivos (RDGL) Non-cash Items (2018 - 2025)

Vivos (RDGL) reported Non-cash Items of $538960.0 for Q4 2025, down 2.41% on a YoY basis from $552276.0 in Q4 2024, and up 1004.13% sequentially from $48813.0 in Q3 2025.

Vivos (RDGL) Non-cash Items (2018 - 2025) Analysis & Trends

Vivos (RDGL) has 8 years of Non-cash Items data on file, last reported at $538960.0 in Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 2.41% year-over-year to $538960.0; the trailing twelve-month figure through Dec 2025 stood at $1.0 million (down 17.79% YoY), and the FY2025 full-year result was $1.0 million, down 17.79% from the prior year.
  • Non-cash Items grew to $538960.0 in Q4 2025, from $48813.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $1.5 million in Q2 2021 to a low of -$57238.0 in Q4 2021.
  • A 5-year average of $337523.2 and a median of $317306.5 in 2022 frame the typical range for Non-cash Items.
  • Across the five-year window, Non-cash Items tumbled 125.6% in 2022 and soared 7643.87% in 2023, its largest moves.
  • Tracing RDGL's Non-cash Items over 5 years: stood at -$57238.0 in 2021, then surged by 840.74% to $423986.0 in 2022, then soared by 44.6% to $613082.0 in 2023, then dropped by 9.92% to $552276.0 in 2024, then fell by 2.41% to $538960.0 in 2025.
  • Business Quant data shows RDGL's Non-cash Items at $538960.0 in Q4 2025, $48813.0 in Q3 2025, and $41003.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.86 Bn 175.56 Bn 6.27 Bn
2 Stryker 128.95 Bn 126.07 Bn 3.81 Bn
3 Medtronic 108.31 Bn 99.09 Bn 6.41 Bn
4 Boston Scientific 68.46 Bn 67.01 Bn 3.61 Bn
5 Edwards Lifesciences 48.25 Bn 44.58 Bn 1.29 Bn
6 Dexcom 28.35 Bn 27.23 Bn 750.30 Mn
7 GE HealthCare Technologies 28.05 Bn 25.76 Bn 1.98 Bn
8 Smith & Nephew 26.96 Bn 26.38 Bn -
9 Koninklijke Philips 24.06 Bn 20.93 Bn 2.07 Bn
10 Vivos 27.62 Mn 26.06 Mn -3,105.00

Historic Data

Download Data
DateValue
Dec 31, 2025 538,960.00
Dec 31, 2025 538,960.00
Sep 30, 2025 48,813.00
Sep 30, 2025 48,813.00
Jun 30, 2025 41,003.00
Jun 30, 2025 41,003.00
Mar 31, 2025 379,498.00
Mar 31, 2025 379,498.00
Dec 31, 2024 552,276.00
Dec 31, 2024 552,276.00
Sep 30, 2024 319,006.00
Sep 30, 2024 319,006.00
Jun 30, 2024 148,046.00
Jun 30, 2024 148,046.00
Mar 31, 2024 207,081.00
Mar 31, 2024 207,081.00
Dec 31, 2023 613,082.00
Dec 31, 2023 613,082.00
Sep 30, 2023 445,767.00
Sep 30, 2023 445,767.00